Home » Stocks » Zivo Bioscience

Zivo Bioscience Inc. (ZIVO)

Stock Price: $0.110 USD 0.000 (0.00%)
Updated Aug 4, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 44.73M
Revenue (ttm) 20,000
Net Income (ttm) -11.00M
Shares Out 406.64M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $0.110
Previous Close $0.110
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.103
Day's Range 0.103 - 0.108
Day's Volume 72,540
52-Week Range 0.050 - 0.175

More Stats

Market Cap 44.73M
Enterprise Value 49.95M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 406.64M
Float 238.78M
EPS (basic) -0.04
EPS (diluted) -0.03
FCF / Share -0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.51
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2,236.49
PB Ratio n/a
Revenue 20,000
Operating Income -9.79M
Net Income -11.00M
Free Cash Flow -3.91M
Net Cash -5.22M
Net Cash / Share -0.01
Gross Margin n/a
Operating Margin -48,953.10%
Profit Margin -54,980.70%
FCF Margin -19,570.66%
ROA -4,329.44%
ROE n/a
ROIC 272.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth--------25.59%-
Gross Profit---------0.030.03
Operating Income-8.35-6.13-6.33-3.49-3.06-5.15-3.11-2.08-1.94-4.06
Net Income-11.51-14.64-10.04-6.06-5.790.68-10.10-3.25-2.73-7.12
Shares Outstanding27615713913413112511210196.5887.16
Earnings Per Share-0.04-0.09-0.07-0.05-0.04--0.09-0.03-0.03-0.08
Operating Cash Flow-3.71-5.01-4.24-2.54-2.30-2.74-2.99-1.77-1.29-1.44
Capital Expenditures----------0.03
Free Cash Flow-3.71-5.01-4.24-2.54-2.30-2.74-2.99-1.78-1.30-1.47
Cash & Equivalents0.350.390.320.510.020.000.490.170.350.14
Total Debt5.2818.1513.9610.316.164.012.511.340.520.28
Net Cash / Debt-4.93-17.77-13.64-9.80-6.14-4.01-2.02-1.16-0.17-0.14
Book Value-8.34-22.28-16.30-13.62-9.50-6.37-9.59-3.96-2.03-0.95
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Zivo Bioscience Inc.
Country United States
Employees 5
CEO Andrew A. Dahl

Stock Information

Ticker Symbol ZIVO
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: ZIVO


ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and marketing natural bioactive ingredients derived from its proprietary algal cultures. The company provides its natural bioactive ingredients to animal, human and dietary supplement, and medical food manufacturers; and intends to license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that would allow people to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Keego Harbor, Michigan.